Back
Regeneron Pharmaceuticals 10K Form
Sell
40
REGN
Regeneron Pharmaceuticals
Last Price:
$696.47
Seasonality Move:
1.02%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-05-02 | 10Q | REGN/Regeneron Pharmaceuticals Quarterly |
2023-11-02 | 10Q | REGN/Regeneron Pharmaceuticals Quarterly |
2023-08-03 | 10Q | REGN/Regeneron Pharmaceuticals Quarterly |
2023-05-04 | 10Q | REGN/Regeneron Pharmaceuticals Quarterly |
2022-11-03 | 10Q | REGN/Regeneron Pharmaceuticals Quarterly |
2022-08-03 | 10Q | REGN/Regeneron Pharmaceuticals Quarterly |
Receive REGN News And Ratings
See the #1 stock for the next 7 days that we like better than REGN
REGN Financial Statistics
Sales & Book Value
Annual Sales: | $14.2B |
---|---|
Cash Flow: | $995.8M |
Price / Cash Flow: | 22.3 |
Annual Sales: | $267.78 |
Price / Book: | 2.55 |
Profitability
EPS (TTM): | 38.28000 |
---|---|
Net Income (TTM): | $4.4B |
Gross Margin: | $12.2B |
Return on Equity: | 15.78% |
Return on Assets: | 12.34% |
Regeneron Pharmaceuticals Earnings Forecast
Key Regeneron Pharmaceuticals Financial Ratios
-
The Gross Profit Margin over the past 35 years for REGN is 86.13%.
-
The Selling, General & Administrative Expenses for REGN have been equal to 20.80% of Gross Profit Margin.
-
The Research & Development expenses have been 36.14% of Revenue.
-
The Interest Expense is 1.25% of Operating Income.
-
The Net Earning history of REGN is 31.07% of Total Revenues.
-
Per Share Earnings over the last 35 years have been positive in 19 years.
Regeneron Pharmaceuticals Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | S&P500 |
---|---|
Industry: | Biotechnology |
Sector: | Health Care |
Current Symbol: | REGN |
CUSIP: | 75886F |
Website: | regeneron.com |
Debt
Debt-to-Equity Ratio: | 0.07 |
---|---|
Current Ratio: | 4.73 |
Quick Ratio: | 3.86 |
Price-to-Earnings
Trailing P/E Ratio: | 17.88 |
---|---|
Forward P/E Ratio: | 14.57 |
REGN Technical Analysis vs Fundamental Analysis
Sell
40
Regeneron Pharmaceuticals (REGN)
is a Sell
Is Regeneron Pharmaceuticals a Buy or a Sell?
-
Regeneron Pharmaceuticals stock is rated a SellThe current Regeneron Pharmaceuticals [REGN] share price is $685.66. The Score for REGN is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.